Role of the T-type calcium channel CaV3.2 in the chronotropic action of corticosteroids in isolated rat ventricular myocytes

Endocrinology

Volumn 150, Issue 8, 2009, Pages 3726-3734

  Maturana, Andrés ^a   Lenglet, Sébastien ^c   Python, Magaly ^c   Kuroda, Shun'Ichi ^b   Rossier, Michel F ^c,d  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d University Hospital   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL CAV3.2; CALCIUM CHANNEL T TYPE; CORTICOSTEROID DERIVATIVE; NICKEL; OXIDIZING AGENT; REDUCING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHRONOTROPISM; CONTROLLED STUDY; MUSCLE FIBER CONTRACTION; NEWBORN; NONHUMAN; OXIDATION REDUCTION STATE; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SENSITIVITY ANALYSIS;

ADRENAL CORTEX HORMONES; ALDOSTERONE; ANIMALS; ANIMALS, NEWBORN; CALCIUM CHANNELS, T-TYPE; CELLS, CULTURED; ELECTROPHYSIOLOGY; GENE EXPRESSION; HEART VENTRICLES; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 67651148201     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1727     Document Type: Article

References (55)

1. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709-717
2. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M 2003 Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309-1321
3. Ramires FJ, Mansur A, Coelho O, Maranhão M, Gruppi CJ, Mady C, Ramires JA 2000 Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 85:1207-1211
4. Cittadini A, Monti MG, Isgaard J, Casaburi C, Strömer H, Di Gianni A, Serpico R, Saldamarco L, Vanasia M, Saccà L 2003 Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure. Cardiovasc Res 58:555-564
5. Perrier E, Kerfant BG, Lalevee N, Bideaux P, Rossier MF, Richard S, Gómez AM, Benitah JP 2004 Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction. Circulation 110:776-783
6. Chai W, Danser AH 2006 Why are mineralocorticoid receptor antagonists cardioprotective? Naunyn Schmiedebergs Arch Pharmacol 374:153-162
7. Abdo A, Bebb RA, Wilkins GE 1999 Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism. Can J Cardiol 15:347-348
8. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243-1248
9. Geist M, Dorian P, Davies T, Greene M, Newman D 1996 Hyperaldosteronism and sudden cardiac death. Am J Cardiol 78:605-606
10. Halonen J, Halonen P, Järvinen O, Taskinen P, Auvinen T, Tarkka M, Hippeläinen M, Juvonen T, Hartikainen J, Hakala T 2007 Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA 297:1562-1567
11. Tsai MS, Huang CH, Chang WT, Chen WJ, Hsu CY, Hsieh CC, Yang CW, Chiang WC, Ma MH, Chen SC 2007 The effect of hydrocortisone on the outcome of out-of-hospital cardiac arrest patients: a pilot study. Am J Emerg Med 25:318-325
12. Güder G, Bauersachs J, Frantz S, Weismann D, Allolio B, Ertl G, Angermann CE, Störk S 2007 Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation 115:1754-1761
13. Souverein PC, Berard A, Van Staa TP, Cooper C, Egberts AC, Leufkens HG, Walker BR 2004 Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 90:859-865
14. Funder JW 2004 Is aldosterone bad for the heart? Trends Endocrinol Metab 15:139-142
15. Benitah JP, Gomez AM, Virsolvy A, Richard S 2003 New perspectives on the key role of calcium in the progression of heart disease. J Muscle Res Cell Motil 24:275-283
16. Nuss HB, Houser SR 1993 T-type calcium current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 73:777-782
17. Sen L, Smith TW 1994 T-type calcium channels are abnormal in genetically determined cardiomyopathic hamster hearts. Circ Res 75:149-155
18. 2+ channels in the heart. Cell Calcium 40:205-220
19. v3.1d) in developing mouse heart. Circ Res 88:403-407
20. Xu X, Best PM 1992 Postnatal changes in T-type calcium current density in rat atrial myocytes. J Physiol (Lond) 454:657-672
21. 2+ channel during fetal and postnatal rat heart development. J Mol Cell Cardiol 34:533-546
22. 2+ channels in ventricular cells from hypertrophied rat hearts. J Mol Cell Cardiol 31:1617-1625
23. Leuranguer V, Monteil A, Bourinet E, Dayanithi G, Nargeot J 2000 T-type calcium currents in rat cardiomyocytes during postnatal development: contribution to hormone secretion. Am J Physiol Heart Circ Physiol 279:H2540-H2548
24. 2+ channel in murine hearts during the embryonic period. Am J Physiol Heart Circ Physiol 286:H2257-H2263
25. Rossier MF, Lenglet S, Vetterli L, Python M, Maturana A 2008 Corticosteroids and redox potential modulate spontaneous contractions in isolated rat ventricular cardiomyocytes. Hypertension 52:721-728
26. Lalevée N, Rebsamen MC, Barrère-Lemaire S, Perrier E, Nargeot J, Bénitah JP, Rossier MF 2005 Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes. Cardiovasc Res 67:216-224
27. Springhorn JP, Claycomb WC 1989 Preproenkephalin mRNA expression in developing rat heart and in cultured ventricular cardiac muscle cells. Biochem J 258:73-78
28. Tuschl T 2002 Expanding small RNA interference. Nat Biotechnol 20:446-448
29. Maturana AD, Wälchli S, Iwata M, Ryser S, Van Lint J, Hoshijima M, Schlegel W, Ikeda Y, Tanizawa K, Kuroda S 2008 Enigma homolog 1 scaffolds protein kinase D1 to regulate the activity of the cardiac L-type voltage-gated calcium channel. Cardiovasc Res 78:458-465
30. Lee JH, Gomora JC, Cribbs LL, Perez-Reyes E 1999 Nickel block of three cloned T-type calcium channels: low concentrations selectively block α1H. Biophys J 77:3034-3042
31. Piwien-Pilipuk G, Galigniana MD 2000 Oxidative stress induced by L-buthionine-(S,R)-sulfoximine, a selective inhibitor of glutathione metabolism, abrogates mouse kidney mineralocorticoid receptor function. Biochim Biophys Acta 1495:263-280
32. Pitt B, Williams G, Remme W, Martinez F, Lopez-Sendon J, Zannad F, Neaton J, Roniker B, Hurley S, Burns D, Bittman R, Kleiman J 2001 The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther 15:79-87
33. Yoshimoto T, Hirata Y 2007 Aldosterone as a cardiovascular risk hormone. Endocr J 54:359-370
34. Ram R, Van Wagoner DR 2006 Aldosterone antagonism as an antiarrhythmic approach for atrial arrhythmias in heart failure. J Cardiovasc Electrophysiol 17:542-543
35. Irisawa H, Brown HF, Giles W 1993 Cardiac pacemaking in the sinoatrial node. Physiol Rev 73:197-227
36. Barbuti A, Baruscotti M, DiFrancesco D 2007 The pacemaker current: from basics to the clinics. J Cardiovasc Electrophysiol 18:342-347
37. f current and spontaneous activity in mouse embryonic ventricular myocytes. Circ Res 88:536-542
38. f, in ventricular myocytes from human failing heart. Circulation 95:568-571
39. Hoppe UC, Jansen E, Südkamp M, Beuckelmann DJ 1998 Hyperpolarization-activated inward current in ventricular myocytes from normal and failing human hearts. Circulation 97:55-65
40. f) and hyperpolarization-activated cyclic nucleotide-gated channel mRNA expression in ventricular cells from control and hypertrophied rat hearts. J Physiol 553:395-405
41. f current through gene expression in cultured neonatal rat ventricular myocytes. Am J Physiol Heart Circ Physiol 293:H2710-H2718
42. Beuckelmann DJ, Näbauer M, Erdmann E 1991 Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol 23:929-937
43. Marionneau C, Couette B, Liu J, Li H, Mangoni ME, Nargeot J, Lei M, Escande D, Demolombe S 2005 Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. J Physiol 562:223-234
44. Kawano S, DeHaan RL 1991 Developmental changes in the calcium currents in embryonic chick ventricular myocytes. J Membr Biol 120:17-28
45. 2+ channel gene and current in post-infarction remodeled rat left ventricle. Cardiovasc Res 46:442-449
46. 2+ channel: regulation of CACNA1H by neuron-restrictive silencer factor. J Pharmacol Sci 99:211-213
47. Ca,L in rabbit sinus node cells. Eur J Pharmacol 401:27-30
48. 2+ channels in cardiac pacemaking. J Pharmacol Sci 99:197-204
49. 2+ currents by efonidipine: possible mechanism for its chronotropic effect. Eur J Pharmacol 349:351-357
50. Mádle A, Linhartová K, Koza J 2001 Effects of the T-type calcium channel blockade with oral mibefradil on the electrophysiologic properties of the human heart. Med Sci Monit 7:74-77
51. Bénitah JP, Vassort G 1999 Aldosterone upregulates calcium current in adult rat cardiomyocytes. Circ Res 85:1139-1145
52. Rougier JS, Muller O, Berger S, Centeno G, Schütz G, Firsov D, Abriel H 2008 Mineralocorticoid receptor is essential for corticosteroid-induced up-regulation of L-type calcium currents in cultured neonatal cardiomyocytes. Pflugers Arch 456:407-412
53. Rossier MF 2003 Function and differential expression of T-type calcium channels in various pathophysiological states. Recent Res Dev Biochem 4:13-29
54. Ferron L, Capuano V, Ruchon Y, Deroubaix E, Coulombe A, Renaud JF 2003 Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels. Circ Res 93:1241-1248
55. Nelson MT, Joksovic PM, Su P, Kang HW, Van Deusen A, Baumgart JP, David LS, Snutch TP, Barrett PQ, Lee JH, Zorumski CF, Perez-Reyes E, Todorovic SM 2007 Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate. J Neurosci 27:12577-12583